Target intelligence / Profile preview

Hepatocyte endosomal membrane

Molecular classification
Other
01

Overview

The hepatocyte endosomal membrane is a specialized lipid bilayer that defines the boundary of endocytic vesicles within liver cells. It plays a central role in the sorting and trafficking of internalized molecules, including nutrients, signaling receptors, and therapeutic agents. In modern pharmacology, this membrane represents a critical barrier for the delivery of macromolecular drugs, such as siRNA and mRNA, which must escape the endosomal compartment to reach their intracellular targets in the cytoplasm. Furthermore, the hepatocyte endosomal membrane is a key site for the entry of certain viruses, such as the Hepatitis C virus (HCV), which undergoes pH-dependent fusion with this membrane to release its genetic material. While it is a vital component of cellular physiology and a major consideration in drug delivery design, it is classified as a cellular structure or compartment rather than a single molecular target like a protein or enzyme.

Other names
Liver endosomal membraneHepatocyte endosome membraneHepatic endosomal membrane
02

Mechanism of action

Therapeutic agents, particularly RNA-based drugs, utilize receptor-mediated endocytosis to enter hepatocytes and must subsequently achieve endosomal escape across this membrane to reach the cytosol. Antiviral strategies may involve inhibiting the fusion of viral envelopes with the hepatocyte endosomal membrane, a process often triggered by the acidic environment within the endosome.

03

Biological functions

EndocytosisEndosomal escapeIntracellular traffickingViral entryProtein sortingAcidification
04

Disease associations

InfectionGenetic diseaseMetabolic diseaseCancer
05

Safety considerations

Endosomal entrapmentLysosomal degradationMembrane disruption-induced toxicityOff-target accumulation
06

Interacting drugs

Givosiran

6 more in the full profile.

07

Biomarkers

Asialoglycoprotein receptor 1 (ASGR1) expressionEndosomal pHHepatitis C virus (HCV) RNA levelsLow-density lipoprotein receptor (LDLR) expression

Beyond the preview

Go deeper on Hepatocyte endosomal membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte endosomal membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call